Hourly refreshWed, Sep 2, 2026

Press Release Database

Recent press releases, indexed by topic.
Topic

Healthcare

6,364 press releases indexed under healthcare.

AllFinanceCryptoAISaaSHealthcareReal EstateEnergyRetailAutomotiveGamingMediaEducation
DownloadExcelTXT
Finance · AI

World No.1 with 56% Profit Surge: Saint Bella Redefines Family Care Economics

HONG KONG, Sep 2, 2026 - (ACN Newswire) - Postpartum care has historically presented a challenging unit economic profile: low purchase frequency, high labor intensity, and significant execution friction across regions. Constrained by these structural headwinds, most industry operators operate near break-even levels. Saint Bella Group (2508.HK), the world’s largest postpartum care provider by market share, has delivered a set of interim financial results that defies these broader sector dynamics. During the first half, profit growth significantly outpaced top-line expansion—demonstrating strong operational leverage. Five core financial metrics outline the mechanics driving this margin expansion: Revenue and Adjusted Profit Growth: H1 revenue grew 36.0% year-on-year (YoY) to RMB 611 million. Adjusted net profit surged 56.2% YoY to RMB 60.58 million, driving adjusted net margin up to 9.9%. Profit growth outstripped top-line gains as fixed-cost absorption improved. Core Brand Expansion (ASP up 15.9% to RMB 171,000): Across its brand portfolio—Saint Bella, Bella Isla, and Baby Bella (spanning ultra-luxury to upper-mid tiers)—group-wide average selling price (ASP) rose 15.9% YoY to RMB 171,000. Pricing power across core brands expanded despite broader macroeconomic discounting pressures in consumer services. Lifecycle Diversification: Postpartum care revenue grew 31.4% YoY to RMB 508 million. Non-postpartum, full-lifecycle services and products increased their revenue share to 31.5%, led by a 59.1% YoY surge in family care services and a 44.4% YoY gain in women’s health nutrition. Customer Lifetime Value (LTV) & Retention Metrics: The repeat-purchase conversion rate across non-postpartum offerings reached a record 96.3%. Conversion from core postpartum care to STB postpartum recovery services reached 94%. Average contract duration for family care extended to 169 days with a 57% renewal rate, indicating a transition from transactional engagements to multi-period recurring revenue. Global Footprint, Consolidation & AI Monetization: Operating centers in New York, Bangkok, and Singapore expanded operations, driving overseas revenue up 244% YoY. The acquisition of Wuhan-based Freya closed during the period. Proprietary AI agents generated RMB 6.9 million in revenue, marking initial financial validation for the group's technology stack. These operational data points signal a fundamental strategic shift: Saint Bella is transitioning from single-event postpartum care delivery to managing long-term customer lifetime value (LTV) across multiple brands and environments. While traditional peers remain focused on local bed-capacity competition, the industry leader is restructuring its growth flywheel. Core Operations: ASP Expansion, Penetration, and M&A Postpartum care remains Saint Bella’s foundational anchor and primary customer acquisition channel, generating RMB 508 million in H1 revenue (+31.4% YoY). Across its tiered multi-brand structure—Saint Bella, Bella Isla, and Baby Bella—group ASP increased 15.9% YoY to RMB 171,000. Delivering simultaneous volume and price growth sets the group apart in a consumer sector currently marked by price-cutting. Top-line performance is backed by deep service attach rates and high retention. During the reporting period, 94% of postpartum care clients cross-purchased STB postpartum recovery services. With overall repeat-purchase conversion reaching 96.3%, brand equity continues to reinforce customer retention. Saint Bella is executing a dual organic and inorganic growth strategy. The strategic acquisition of Freya—a premium maternal and infant care operator in Wuhan—added three standalone centers, 160 beds, and approximately 10,000 high-net-worth members, resolving a strategic coverage gap in central China. By integrating its standardized operational workflows and higher-margin recovery services into Freya’s network, Saint Bella expects near-term scale efficiencies. As of H1, Saint Bella’s global footprint stood at 148 operating centers. Strategic Pivot: Capturing Full-Lifecycle Customer Value While postpartum care acts as an efficient acquisition vector, full-lifecycle services drive long-term monetization. The Group's monetization sequence follows a structured funnel: Initial Acquisition & Trust: High-net-worth clients enter the funnel through premium postpartum care, establishing foundational brand trust. Postpartum Recovery Cross-Sell: STB services extend engagement beyond the standard 28-day stay, capturing spend across the full physiological recovery cycle. Family Care Retainers: Yujia’s age-tiered early childhood development framework (ages 0–3) extends average contract duration to 169 days, achieving a 57% renewal rate. Health & Nutrition Recurrence: Women’s health nutrition transitions the engagement model into high-frequency, mid-ticket daily wellness spending. This multi-stage model is driving tangible financial shift. Outpacing the core postpartum segment, family care revenue rose 59.1% YoY while health nutrition grew 44.4% YoY, driving non-postpartum revenue to 31.5% of total revenue. Furthermore, the addition of Freya’s ~10,000 member base provides an immediate addressable pool for cross-selling. Scalable Infrastructure: Global Network, Specialized Talent, and AI Execution Executing this expanded service coverage across geographies relies on three key operational pillars: skilled labor supply, international distribution, and standardized quality controls. Talent Development: The group’s certified family care specialist pool reached 11,495 headcount, adding 1,995 newly certified specialists in H1 (+42% vs. H2 of the prior year). In a labor-intensive sector, maintaining a deep talent bench is essential for cross-regional scaling and quality assurance. Global Footprint & Strategic Partnerships: Operating 148 centers worldwide, international sites in New York, Bangkok, and Singapore are progressively scaling operations. Complementing center-based models, an overseas in-home care program drove a 244% YoY increase in international revenue. To accelerate global expansion, Saint Bella entered into a strategic partnership with L Catterton, the consumer-focused private equity firm backed by LVMH. The partnership drives co-developing international market opportunities, introducing global brands, acquiring cross-border talent, and sourcing target M&A candidates. Proprietary AI Deployment: "Dr. Bella," the group's proprietary domain-specific large language model, is deployed across 60+ affiliated brands and 207 postpartum centers. The system automates clinical consultations, dynamic care plan generation, and customer management. AI-driven operations generated RMB 6.9 million in revenue during H1, validating initial technology commercialization. Over the longer term, codifying human service expertise into scalable software protocols enhances cross-center operational consistency and lowers asset-light expansion costs. Outlook Market leadership in the family care sector is shifting away from pure center footprint expansion. Future enterprise value will accrue to platforms capable of establishing early client trust, extending service lifecycles, and standardizing service delivery through digital technology and trained talent pools. According to Frost & Sullivan, Saint Bella ranked first globally by revenue in 2025, capturing a 0.5% market share—leading the second-largest operator by over 47%. While legacy operators remain focused on single-center economics, Saint Bella is leveraging high-end postpartum care as a customer acquisition bridge—building a full-lifecycle, omni-channel family care platform with defensible competitive moats. Copyright 2026 ACN Newswire. All rights reserved. www.acnnewswire.com

Sep 2 · 00:00mlpr-acnnewswire
Healthcare

Care Can’t Wait! Long-Term Care workers hold province wide day of action calling out delays in contract negotiations with Extendicare

Markham, ON, September 01, 2026--For months, 8 CUPE locals representing over 1100 long term care workers across Ontario have been kept waiting for a fair contract. Where other workers would have been able to go on strike to force the employer back to the table, these workers are denied that right under the Hospital Labour Disputes Arbitration Act (HLDAA), forcing them into a long and drawn-out process to get a fair contract.

Sep 1 · 22:28mlpr-businesswire
Finance · Healthcare

Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway

MELBOURNE, Australia and INDIANAPOLIS, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announced completion of patient enrollment in the Phase 3 BiPASS™ study of its commercial PSMA-PET 1 imaging agents, Illuccix® (kit for the preparation of gallium Ga68 gozetotide injection) and Gozellix® (kit for the preparation of gallium Ga68 gozetotide injection) for prostate cancer imaging in the pre-biopsy setting. Telix has also aligned with the United States (U.S.) Food and Drug Administration (FDA) on a New Drug Application (NDA) pathway for BiPASS that, if approved, would support reimbursement as a new product and broaden patient access.

Sep 1 · 22:18GlobeNewswire
Healthcare · Education

AHF Webinar Panel Discussion—Freedom from Debt: A Global Dialogue on Fiscal Space, Health, and Development

MIAMI, September 01, 2026--AIDS Healthcare Foundation (AHF), in collaboration with the University of Miami Public Health Policy Lab, will co-host a webinar, "Freedom from Debt: A Global Dialogue on Fiscal Space, Health, and Development," on Thursday, September 3, 2026, at 10:00 AM EDT, virtually via Zoom. Register here.

Sep 1 · 22:08mlpr-businesswire
Finance · Healthcare

Pennant Group to Participate in the 2026 Jefferies Healthcare Services Conference

EAGLE, Idaho, Sept. 01, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it will participate in the upcoming 2026 Jefferies Healthcare Services Conference on September 15, 2026.

Sep 1 · 22:07GlobeNewswire
Healthcare

Knight Therapeutics Announces Regulatory Approval of TAVALISSE® in Colombia

MONTREAL, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. ("Knight") (TSX: GUD), a pan-American (ex-US) pharmaceutical company, announced today that it has received regulatory approval from INVIMA, the Colombian health regulatory agency, for TAVALISSE ® (fostamatinib disodium hexahydrate) for the treatment of adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response, loss of response, or intolerance to prior treatment with corticosteroids and intravenous immunoglobulin. 1

Sep 1 · 22:00GlobeNewswire
Healthcare

Feinstein Institutes’ researchers find jumping genes at the center of blood immune networks disrupted in schizophrenia

MANHASSET, N.Y., September 01, 2026--Unlocking a crucial piece of schizophrenia’s molecular puzzle, scientists at Northwell Health’s Feinstein Institutes for Medical Research have found that jumping genes, also known as transposable elements, are linked to a communication breakdown in the blood gene expression networks of people living with schizophrenia. Jumping genes are DNA sequences from ancient viruses and other elements that could once move around the human genome – and in rare cases still

Sep 1 · 21:28mlpr-businesswire
Healthcare

New National Survey From MedStar Health Finds Many Men Over 55 Are Missing Prostate Cancer Screening

COLUMBIA, Md., Sept. 1, 2026 /PRNewswire/ -- A new national survey from MedStar Health suggests millions of men age 55 and older may be missing chances to get screened for prostate cancer, even though it is one of the most common cancers in men. Of surveyed men age 55 and older, 30% have...

Sep 1 · 21:26PR Newswire
Healthcare

MindMaze Therapeutics to Present at Upcoming Investor and Industry Conferences

GENEVA, SWITZERLAND - September 1, 2026 ( NEWMEDIAWIRE ) - MindMaze Therapeutics Holding SA (SIX: MMTX ) (MindMaze Therapeutics or the Company), a global leader in scalable precision neurotherapeutics, today announced its participation in several upcoming investor and industry conferences in the United States and Europe. Investor Conferences Conference: Baader Investment Conference Location: Munich, Germany Presentation: September 21, 2026 at 5:40 p.m. CET Conference: Global Markets Forum Location: New York, NY Presentation: October 7, 2026 Management will be available for one-on-one meetings. Investors interested in meeting with the Company are invited to contact ir@mindmazetherapeutics.com. Industry Conferences Conference: American Medical Rehabilitation Providers Association (AMRPA) Edu

Sep 1 · 21:23NewMediaWire
AI · SaaS

Paubox Opens HIPAA Compliant Forms to AI Agents

SAN FRANCISCO, September 01, 2026--Paubox has made its HIPAA compliant forms callable by AI agents. An agent can pull a form's questions, collect a patient's answers in conversation, and submit the completed response into Paubox. The record lands under the same business associate agreement (BAA) that covers the rest of the platform.

Sep 1 · 21:16mlpr-businesswire
Finance · Healthcare

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment approach for ovarian cancer, today announced that on September 1, 2026, the Compensation Committee of Zentalis’ Board of Directors granted non-qualified stock options to purchase an aggregate of 269,000 shares of the Company’s common stock to four (4) newly hired employees. The stock options were granted under the Zentalis Pharmaceuticals, Inc. 2022 Employment Inducement Incentive Award Plan (2022 Inducement Plan) as an inducement material to each such individual’s entering into employment with Zentalis in accordance with Nasdaq Listing Rule 5

Sep 1 · 21:15GlobeNewswire
Finance · Healthcare

NeuroPace to Participate in 2026 Cantor Global Healthcare Conference

MOUNTAIN VIEW, Calif., September 01, 2026--NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will participate in the upcoming 2026 Cantor Global Healthcare Conference.

Sep 1 · 21:01mlpr-businesswire
← Prev123531Next →